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cDNA complementary to mRNA coding for the elongation factor EF-1P has been cloned. A 1gt 11 cDNA 
library has been screened with an antiserum against EF-l/3 which exchanges GDP bound to EF-la with 
exogenous GTP during protein synthesis. The derived amino acid sequence corresponds to 208 amino acids 
including the N-terminal methionine which is absent in the mature protein. About sixty percent of the pro- 
tein was sequenced by direct protein sequence analysis. Comparison of Artemia salina EF-ID with Escher- 
ichia coli EF-Ts shows no evident homology. 
(Artemia salina) Protein synthesis Elongation factor I/I Guanine nucleotide exchange protein 
Nucleotide sequence cDNA cloning Aggt 11 phage library 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Besides elongation factor EF-lcu, which 
mediates the GTP-dependent binding of aminoacyl 
tRNA to the 80 S ribosome [ 11, eukaryotes possess 
a second elongation factor EF-Ifly, which is func- 
tionally analogous to prokaryotic elongation fac- 
tor EF-Ts. This factor is composed of two subunits 
p and y, and catalyzes the exchange of GDP bound 
to EF-1~ for GTP via an intermediary, ternary 
EF-la. EF-I,& nucleotide complex [2-41. It has 
been shown that the actual exchange activity 
resides in EF-I,& whereas the function of EF-ly is 
still unknown [4-71. 
2.1. Materials 
A. safina cysts were obtained from Metaframe 
(San Francisco), peroxidase-conjugated goat anti- 
rabbit antibodies were obtained from Miles and 
Freund’s adjuvant was purchased from 
CalBiochem. 32P-labelled nucleotides and nick- 
translation kits were purchased from Amersham. 
Enzymes were from Boehringer or Promega. The 
other chemicals were of the highest grade commer- 
cially available. 
2.2. Preparations 
This paper reports on the successful cloning of 
A. safina EF-I,& and the nucleotide sequence of its 
cDNA. Most of the cDNA-predicted amino acid 
sequence was confirmed independently by direct 
protein sequencing of a number of mainly tryptic 
peptides. Comparison of the primary structure of 
A. salina EF-lb with the deduced amino acid se- 
quence of E. coli EF-Ts [8] revealed low, if any 
homology, suggesting less restriction with respect 
to changes in primary structure than in the cor- 
responding case of A. salina EF-lcu and E. coli EF- 
Tu [9]. 
EF-lp was prepared according to a new method 
the details of which will appear elsewhere. The 
following steps were used: DEAE-cellulose 
chromatography, phenyl-Sepharose chromatog- 
raphy and DEAE-cellulose (6 M urea) chroma- 
tography to separate the protein chains p and y [3]. 
Occasionally, the &complex was separated on a 
Sephacryl S300 column in the presence of 0.1% 
SDS and 50 mM sodium bicarbonate, pH 9.0 [lo]. 
* To whom correspondence should be addressed 
During the final purification step of EF-l/Y 
(dialysis against 5 mM sodium pyrophosphate, pH 
6.0, 2.5 mM MgClz), a distinct fragment of the 
protein was gradually formed, which had an M, on 
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SDS-polyacrylamide gels of about 14000. This 
fragment was purified on reverse-phase HPLC, as 
described in fig.la, and used for sequence analysis 
as well. 
2.3. Protein sequence analysis 
S-Pyridylethylation of EF-lb and its 14000 Da 
fragment (see above) was performed as described 
in [ll]. The intact protein was also S- 
carboxymethylated according to a procedure 
suitable for small amounts of protein [lo]. 
Electroelution from polyacrylamide gels of a 
BrCN-generated fragment of EF-I,0 was per- 
formed as described [lo]. Tryptic peptides were 
separated on a Waters PBondapak Cl8 column 
(see the legends of fig.lb and c). Typically 
4-5 nmol peptide were used for sequencing in a 
Beckman model 890 C sequencer. Polybrene 
(3 mg) was added to the peptide, and a 0.25 M 
Quadrol programme was used. PTH-amino acids 
were identified by reverse-phase HPLC as de- 
scribed [12]. 
2.4. Construction of a cDNA library in hgt 11 
Total RNA was extracted from A. salina cysts, 
which had been developed for 16 h at 27°C in ar- 
tificial sea water, by the urea/LiCl procedure [13]. 
Poly(A)-rich RNA was isolated as in [14]. Total 
poly(A)-rich RNA was used for cDNA synthesis 
according to [ 151. EcoRI sites in cDNA were 
methylated, and the cDNA was ligated with EcoRI 
linkers (Boehringer) and digested with EcoRI as 
described [16]. The modified cDNA was separated 
according to size on a Sepharose CL 2B column. A 
cDNA library was constructed in the arms of 
phage Agt 11 and subsequently packaged in vitro 
using the Promega and Amersham kits, respective- 
ly. Starting from 1 pg of poly(A)-rich RNA a 
library of approx. 2.5 x 10’ recombinants was ob- 
tained. 
2.5. Immunological screening 
Purified EF-l,& was used to raise an antiserum in 
a rabbit. 1 mg of the protein was injected in com- 
plete Freund’s adjuvant followed by a booster of 
0.5 mg after 30 days. The serum was collected 10 
days later. 
The library was plated out onto E. coli strain 
Y 1090 at lo5 plaque-forming units and incubated 
for 4 h at 37°C. A filter soaked in 10 mM IPTG 
@3-D-thiogalactopyranoside) was placed on the top 
agar and the plates were incubated overnight. The 
filters were removed, washed in 6 x STE, 1% 
NP-40 (Nonidet P-40) during 5 min and prein- 
cubated in 1 x STE, 1% BSA (1 x STE = 10 mM 
Tris-HCl, pH 7.4, 100 mM NaCl, 0.1 mM 
EDTA). The filters were incubated for 16 h at 4°C 
in the antiserum buffer: 6 x STE, 1% NP-40, 
polyclonal rabbit anti-EF- l/3 (l/100 dilution) and 
Y 1090 lysate (l/40 dilution). The filters were 
washed twice for 20 min at 37°C with each of the 
following solutions: 3 x STE, 1% BSA; 1 x STE, 
Fig. 1. (a) Purification of the large (proteolytic) fragment of EF-l/3 by reverse-phase HPLC. A sample of about 5 nmol 
was injected onto a wide-pore C 18-column (Baker no.RP 7104-o; 4.6 x 250 mm). The column was developed with a 
gradient of acetonitrile in 0.1% (v/v) trifluoroacetic acid as indicated, at a speed of 1 ml/min. The largest fragment 
appeared for unknown reasons as a doublet, indicated as Ia/Ib. (b) Tryptic peptide mapping of the peptides obtained 
from the 14 kDa fragment of EF-lb. A sample of about 8 nmol (previously S-alkylated with 4-vinylpyridine and tributyl 
phosphine, see Ill]) was digested with trypsin in 1 ml of 0.2 M ammonium carbonate (pH 8.5) for 1 h at 37°C with 
lO,~l TPCK-trypsin (Worthington), and subsequently injected onto a /tBondapak C 18 column. I, WYK*; II, 
APSDKFPY*; III, GQEQLNELLANK*; IV, SYLQGYEPSQEDVAAFNQLNK *. *, The peptide was sequenced to the 
end; underlining indicates a correction for this residue with respect to a previous report [3]. (c) Tryptic peptide mapping 
of the peptides obtained from S-carboxymethylated EF-I,8 (see legend of fig.lb). A sample of about 10 nmol was 
digested with trypsin and chromatographed as described above. I, AYSDKK*; II, skkPAIVAK*; III, WYK*; IV, 
HISSF*; V, N-terminal blocked peptide (see text); VI, APSDKFPY*; VII, a mixture of two peptides, 
GQEQLNELLAIjK* and AEKGQEQLNEL---; VIII, SVQMDGLVWGAAK*; IX and X, both peaks were mixtures of 
the peptides GFPGIPTxAA-EE--- and SYLQGYEPS---; XI, SSVILDIKPWDDETDMAEMEK*; XII, 
ISEFEDFVQSVDIAAFljK*. The sequence following the methionine residue z VIII was also confirmed by analysis of 
a BrCN-generated peptide. The peptide mixtures IX and X were, prior to their sequencing, resolved into their 
constituent peptides by rechromatography on the same reverse-phase column and with the same gradient system, but 
in the presence of 10 mM t-butylammonium acetate, pH 6.0, instead of 0.1% (v/v) trifluoroacetic acid (not shown). 
* and underlining are as in (b). 
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1% NP-40; and 1 x STE, 1% BSA. Then, the 
filters were incubated for 1 h in 4.5 x STE, 1% 
NP-40, peroxidase-conjugated goat anti-rabbit 
IgG (l/100 dilution) and the Y 1090 lysate (l/40 
dilution). The filters were washed twice for 20 min 
at 37°C with each of the following solutions: 3 x 
STE, 1% BSA; 1 x STE, 1% NP-40; and 
phosphate-buffered saline. a-Chloronaphthol was 
used as a substrate for the peroxidase reaction. 
Immunologically positive clones were sub- 
cloned in PUC 8 and these subclones were also 
screened with a synthetic oligonucleotide probe 
5’ -dTG(A,T,C,G)ACGAAGTC(T,C)TCAAG- 
(T,C)TC-3’ which was synthesized on the basis of 
the underlined part of the tryptic peptide IS- 
EFEDFVQSVDIAAFNK of EF-I,&. Conditions 
of hybridization and washing were as in [17]. 
2.6. DNA sequencing analysis 
Sequencing was performed according to the se- 
quencing technique of Maxam and Gilbert [18]. 
2.7. RNA and DNA blot analysis 
RNA samples were electrophoresed on a 1.5% 
agarose gel containing 2.2 M formaldehyde [19] 
and subsequently blotted onto nitrocellulose and 
hybridized as described [20]. 
Restriction fragments of digested DNA were 
separated on a 0.8% agarose gel by electrophoresis 
and transferred to gene screen plus [NEN] by 
alkaline blotting [21]. Hybridization and washing 
of the sheets were as in [20]. 
3. RESULTS AND DISCUSSION 
Fig. la shows the chromatographic purification 
of the 14 kDa fragment of EF-I,& fig.lb and c 
shows the separation of the tryptic peptides, de- 
rived from the 14 kDa fragment and the intact pro- 
tein, respectively. The amino acid sequences of the 
peptides analyzed are indicated in the legends. One 
of the peptides (XII in fig.lc) was used to syn- 
thesize an oligonucleotide probe (see section 2). 
This probe was used for rescreening the recom- 
binants that were subcloned into PUC 8. These 
recombinants were previously selected im- 
munologically from 10’ recombinant _ phages. In 
this way clone B4 was picked up. Using this clone 
as probe, three of the four immunological positive 
80 
Fig.2. Sequencing strategy of the overlapping cDNA 
clones B4 and B27. Relevant restriction sites are 
indicated. Arrows indicate sequencing from a given site. 
N, NcoI; S, Suu3AI; T, TuqI. Both strands of the cDNA 
were sequenced. 
Fig.3. The combined sequences of the cDNA clones B4 
and B27 coding for A. saliva EF-I,&. The derived amino 
acid sequence is shown in the one letter code above the 
cDNA sequence. Peptides found by direct protein 
sequencing are marked by - and cover some 60% of 
the total sequence; - - - , indicates uncertain residues. 
The polyadenylation signal is underlined. The only 
difference between sequences derived from the cDNA 
and direct protein sequencing is indicated by *. 
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clones appeared to be an EF-l,f3 clone. On rescreen- 
ing the phage library with clone B4 subsequently 
another clone B27 was picked up, which had an 
overlapping sequence with B4. Together these 
clones contained the complete coding sequence for 
EF-l/3. 
The sequencing strategy for EF-lfl is given in 
fig.2. Fig.3 depicts the cDNA sequence and the 
derived amino acid sequence coding for EF-lb of 
A. safina. Fig.4 shows the mRNA corresponding 
to EF-I,& as revealed by Northern blot 
hybridization. 
The translational initiation site was assigned to 
the methionine codon at nucleotide position 
26-28. It is the first ATG triplet that appears after 
a nonsense codon TAA at position 1 l-l 3 in the 
same reading frame. The initiation sequence 
AAAATGG at position 23-29 resembles the op- 
timal Kozak initiation sequence ACCATGG [22]. 
The reading frame terminates with the codon TAA 
at position 650-652. The polyadenylation signal 
AATAAA [23] is found at position 680-685. The 
clone B4 has a long poly(A) stretch. 
235 : rRNA 
76s rRNA 
- 
- 
Fig.4. Northern blot analysis of EF-l,f3 mRNA from A. 
salina. The amount of poly(A)-rich RNA used was 3 pg. 
The blot was hybridized with nick-translated clone B4. 
The positions of 16 S and 23 S rRNA of E. coli are 
indicated as markers. 
Fig.5. Maximal ‘homology’ between EF-lb and EF-Ts 
allowing all possible shifts of the chains with respect to 
each other. 
The open reading frame predicts an amino acid 
sequence for the P-subunit of A. salina EF- 1 of 208 
amino acids including the initiator methionine. 
The polypeptide has a calculated M, of 23300 
which is smaller than the M, of 26000 estimated on 
the basis of SDS-polyacrylamide gel elec- 
trophoresis [5]. 
Both EF-l,f3 and the fragment were found to be 
blocked at their amino-terminal end. The initiator 
methionine residue must have been removed dur- 
ing the in vivo processing of the protein, because 
an N-terminal blocked tryptic peptide (V in fig. lc) 
with an amino acid composition corresponding to 
the first six residues following the initiator 
methionine has been found. This is in line with a 
recent report [24] that after removal of the N- 
terminal methionine the next amino acid, if 
alanine, methionine or serine, is frequently 
acetylated. 
Given the functional analogy between the com- 
plex of EF-1~. EF-l& in eukaryotes and of EF- 
Tu. EF-Ts in prokaryotes on one hand and the 
structural homology of EF-la and EF-Tu on the 
other, it is of interest to compare the structure of 
EF-l,f3 and EF-Ts. Although the size, isoelectric 
point and hydrophobicity of EF-I,& and EF-Ts are 
comparable and the functional homology is ob- 
vious, there is little if any primary structural 
homology (see fig.5). There is also hardly any 
resemblance in hydrophilicity pattern (see fig.6). 
Although EF-la is a very conserved protein, 
EF-lfl has almost no homology with its pro- 
karyotic counterpart EF-Ts. It is not yet clear to 
what extent EF-lfi is conserved in eukaryotes. 
interestingly, unlike the y-component, the ,& 
component of EF-I,& can be phosphorylated in 
vitro, using ATP as a phosphate donor; on isoelec- 
tric focusing part of EF-l/3, it turned out to be 
already phosphorylated as such (unpublished 
results). The site and possible functional 
significance of this modification are under in- 
vestigation. 
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EF-lj3 
EF -Ts 
Fig.6. Hydrophilicity pattern of EF-lfl and EF-Ts calculated according to Hopp and Woods [25]. Each point represents 
an average value over six amino acid residues. Positive values indicate hydrophilic regions and negative values 
hydrophobic areas. 
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